January 06, 2025 01:16 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
Sun Pharma launches Palbociclib for advanced breast cancer therapy

Sun Pharma launches Palbociclib for advanced breast cancer therapy

Jan 12, 2023, at 01:21 am

Mumbai: Sun Pharma on Wednesday said it has launched a novel anti-cancer drug, Palbociclib, in India to treat advanced breast cancer, the most common cancer among women in the country.

Five Pharma majors to collab for clinical trial of Molnupiravir drug

Five Pharma majors to collab for clinical trial of Molnupiravir drug

Jun 29, 2021, at 11:54 pm

Hyderabad/UNI: Five Indian pharmaceutical majors joined hands to hold the clinical trial of the investigational and oral anti-viral drug Molnupiravir that inhibits the replication of multiple RNA viruses, including SARS-CoV-2,  meant to treat mild COVID-19 outdoor patients in India.

Ceasing their 2016 distribution deal Sun Pharma and AstraZeneca Pharma enter into a transition supply agreement

Ceasing their 2016 distribution deal Sun Pharma and AstraZeneca Pharma enter into a transition supply agreement

May 29, 2021, at 01:17 am

Mumbai/UNI: AstraZeneca India and Sun Pharma have now discontinued their distribution agreement signed in 2016 and have entered into a transition supply agreement with effect from today.

Sun Pharma starts Phase II clinical trial on AQCH

Sun Pharma starts Phase II clinical trial on AQCH

Jun 05, 2020, at 04:24 pm

Mumbai/UNI: Sun Pharmaceutical Industries said that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19.